Market Introduction
Medicinal Cannabis is now legal in most of the regions across the world. It is crucial to test the cannabis products used for medicinal purposes to avoid side effects. Cannabis testing is used in various applications that include determining the concentration of cannabis in various analytical samples such as pharmaceutical drugs, and detection of contaminants such as bacteria and fungi. Further, the Cannabis testing is also performed for the determination of trace metals, such as arsenic and cadmium that can adversely impact human health if remained unchecked. These tests are performed with the help of various analytical techniques such as chromatography, spectrometry, ELISA, and polymerase chain reaction (PCR).
Market Overview and Dynamics
The Europe cannabis testing market is expected to reach US$ 770.30 million by 2027 from US$ 431.58 million in 2019. The market is anticipated to grow with a CAGR of 7.7% from 2020 to 2027. The growth of the market in the region is attributed to the factors such as increasing government funding and focus for cannabis use and increasing demand for research activities to improve the quality of cannabis. However, the cannabis used as a street drug and trouble with CBD oil are the factors negatively impacting the growth of the market in the coming years.
Key Market Segments
In terms of product, the chromatography instruments segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR in the market during the forecast period. In terms of service, the potency testing segment held the largest share of the market in 2019 and is estimated to register the highest share in the market during the forecast period. In terms of end user, the testing laboratories segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
European Union, National Center for Biotechnology Information, and International Cannabis and Cannabinoids Institute are among the major secondary sources for the Europe cannabis testing market included in the report.
Reasons to buy the report
Europe Cannabis Testing Market Segmentation
By Product
By Service
By End User
Company Profiles
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 431.58 Million |
| Market Size by 2027 | US$ 770.30 Million |
| CAGR (2020 - 2027) | 7.7% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
|
Regions and Countries Covered
|
|
| Europe | UK, Germany, France, Russia, Italy, Rest of Europe |
| Market leaders and key company profiles |
|
The Europe Cannabis Testing Market is valued at US$ 431.58 Million in 2019, it is projected to reach US$ 770.30 Million by 2027.
As per our report Europe Cannabis Testing Market, the market size is valued at US$ 431.58 Million in 2019, projecting it to reach US$ 770.30 Million by 2027. This translates to a CAGR of approximately 7.7% during the forecast period.
The Europe Cannabis Testing Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Cannabis Testing Market report:
The Europe Cannabis Testing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Cannabis Testing Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Cannabis Testing Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)